A Psychoneuroimmunologic Examination of Cumulative Perinatal Steroid Exposures and Preterm Infant Behavioral Follow-Up

Biological Research for Nursing

Volumn 15, Issue 1, 2013, Pages 86-95

  Purdy, Isabell B ^a   Smith, Lynne ^a   Wiley, Dorothy ^b   Badr, Lina ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

behavior; childhood; dexamethasone; neurodevelopment; preterm infant; psychoneuroimmunology; steroids; stress

Indexed keywords

GLUCOCORTICOID;

ADULT; ARTICLE; CHILD BEHAVIOR; ENVIRONMENTAL EXPOSURE; FEMALE; HUMAN; NEWBORN; PREGNANCY; PREMATURITY; PSYCHOPHYSIOLOGY;

ADULT; FEMALE; GLUCOCORTICOIDS; HUMANS; INFANT BEHAVIOR; INFANT, NEWBORN; INFANT, PREMATURE; MATERNAL EXPOSURE; PREGNANCY; PSYCHONEUROIMMUNOLOGY;

EID: 84869852013     PISSN: 10998004     EISSN: 15524175     Source Type: Journal    
DOI: 10.1177/1099800411420134     Document Type: Article

References (52)

1. Achenbach T.,Ruffle T.The child behavior checklist and related forms for assessing behavioral/emotional problems and competencies.Pediatrics in Review. 2001;21:265-271.
2. Adler R.,Felten D.,Cohen N.Psychoneuroimmunology. 2001). Psychoneuroimmunology (3rd ed.). San Diego, CA: Academic Press.San Diego, CA: Academic Press; 2001:.
3. Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants.Pediatrics. 2002;109:330-338.
4. Ballard P.,Ballard R.Scientific basis and therapeutic regimens for use of antenatal glucocorticoids.American Journal of Obstetrics and Gynecology. 1995;181:709-717.
5. Barrington K. J.The adverse neuro-developmental effects of postnatal steroids in the preterm infant: A systematic review of RCTs.BMC Pediatrics. 2001;1:1.
6. Benesova O.,Pavlik A.Perinatal treatment with glucocorticoids and the risk of maldevelopment of the brain.Neuropharmacology. 1989;28:89-97.
7. Bos A.,Dibiasi J.,Tiessen A.,Bergman K.Treating preterm infants at risk for chronic lung disease with dexamethasone leads to an impaired quality of general movements.Biology of the Neonate. 2002;82:155-158.
8. Brazy J.,Eckerman C.,Oehler J.,Goldstein R.,O'Rand A.Nursery neurobiologic risk score: Important factors in predicting outcome in very low birth weight infants.Journal of Pediatrics. 1991;118:783-792.
9. Coe C.,Lubach G.Prenatal influences on neuroimmune set points in infancy.Annals of the New York Academy of Sciences. 2000;917:468-477.
10. Coe C.,Lubach G.Prenatal origins of individual variation in behavior and immunity.Neuroscience and Biobehavioral Reviews. 2005;29:39-49.
11. Crowther C. A.,Doyle L. W.,Haslam R. R.,Hiller J. E.,Harding J. E.,Robinson J. S.,.Outcomes at 2 years of age after repeat doses of antenatal corticosteroids.New England Journal of Medicine. 2007;357:1179-1189.
12. Daruna J. H.Introduction to psychoneuroimmunology. San Diego, CA: Elsevier; 2004:.
13. Doyle L.,Davis P.Postnatal corticosteroids in preterm infants: Systematic review of effects on mortality and motor function.Journal of Paediatric Child Health. 2000;36:101-107.
14. Doyle L.,Ford G.,Rickards A.,Kelly A.,Davis N.,Callanan C.Antenatal corticosteriods and outcome at 14 years of age in children with birth weight less than 1501 grams [Abstract].Pediatrics. 2000;106:e2.
15. Dunlap S.,Archer M.,Quinlivan J.,Beazley L.,Newnham J.Repeated prenatal corticosteroids delay myelination in the ovine central nervous system.Journal of Maternal and Fetal Medicine. 1997;6:309-313.
16. Esplin M.,Fausett M.,Smith S.Multiple courses of antenatal steroids are associated with delay in long-term psychomotor development in children with birth weights ≤ 1500 grams.American Journal of Obstetrics and Gynecology. 2000;182:S24.
17. Fleck B.,McIntosh N.Retinopathy of prematurity. Recent developments.NeoReviews. 2009;10:20-30.
18. French N.,Hagan R.,Evans S.,Godfrey M.,Newnham J.Repeated antenatal corticosteroids: Size at birth and subsequent development.American Journal of Obstetrics and Gynecology. 1999;180:114-121.
19. Gagliardi L.,Cavazza A.,Brunelli A.,Battaglioli M,Merzzi D.,Tandoi F.Assessing mortality risk in very low birthweight infants: A comparison of CRIB, CRIB-II, and SNAPPE-II.Archives of Disease in Children, Fetal Neonatal Edition. 2004;89:F419-F422.
20. Glazer R.,Kiecolt-Glaser R.Stress-induced immune dysfunction: Implications for health.Nature Reviews: Immunology. 2005;5:243-251.
21. Hack M.,Flannery D.,Schluchter M.,Cartar L.,Borawski E.,Klein N.Outcomes of young adulthood for very-low-birth-weight infants.New England Journal of Medicine. 2002;346:149-157.
22. Halliday H. L.,Ehrenkranz R. A.Delayed (> 3 weeks) postnatal corticosteroids for chronic lung disease in preterm infants [online].Cochrane Database of Systematic Reviews. 2001a;2:CD001145.
23. Halliday H. L.,Ehrenkranz R. A.Early postnatal (< 96 hours) corticosteroids for preventing chronic lung disease in preterm infants [online].Cochrane Database of Systematic Reviews. 2001b;1:CD001146.
24. Hille E.,den Ouden A.,Saigal S.,Wolke D.,Lambert M.,Whitaker A.Behavioural problems in children who weigh 1000 g or less at birth in four countries.Lancet. 2001;357:1641-1643.
25. Jobe A.,Ikegami M.Beyond the NIH consensus conference for antenatal glucocorticoids.Neonatal Respiratory Diseases. 2000;10:1-8.
26. Kopelman A.,Moise A.,Holbert D.,Hegemier S.A single very early dexamethasone dose improves respiratory and cardiovascular adaptation in preterm infants.Journal of Pediatrics. 1999;135:345-350.
27. Lefebvre F.,Grégoire M.,Dubois J.,Glorieux J.Nursery neurobiologic risk score and outcome at 18 months.Acta Paediatrica. 1998;87:751-757.
28. Liggins G.,Howie R.A controlled trial of antepartum glucocorticoid treatment for prevention of respiratory distress syndrome in premature infants.Pediatrics. 1972;50:515-525.
29. Lodha A.,Sauvé R,Chen S.,Tang S.,Christianson H.Clinical risk index for babies score for the prediction of neurodevelopmental outcomes at 3 years of age in infants of very low birthweight.Developmental Medicine and Child Neurology. 2009;51:895-900.
30. Mason W.,Koserman R.,Hawkins J.,Herrenkohl T.,Lengua L.,McCauley E.Predicting depression, social phobia, and violence in early adulthood from child behavior problems.Journal of the American Academy of Child and Adolescent Psychiatry. 2004;43:307.
31. Mathews T.,Menacker F.,MacDorman M.Infant morality statistics from 2002 period.Monthly Vital Statistics Report. 2004;53:1-29.
32. Matthews S. G.Antenatal glucocorticoids and the developing brain: Mechanisms of action.Seminars in Neonatology. 2001;6:309-317.
33. Mattia F.,deRegnier A.Chronic physiologic instability is associated with neurodevelopmental morbidity at one and two years in extremely premature infants.Pediatrics. 1998;102:1-14.
34. Moss T. J.,Harding R.,Newnham J. P.Lung function, arterial pressure and growth in sheep during early postnatal life following single and repeated prenatal corticosteroid treatments.Early Human Development. 2002;66:11-24.
35. Consensus development conference statement. Effect of corticosteroids for fetal maturation on perinatal outcomes, February 28-March 2, 1994.American Journal of Obstetrics and Gynecology. 1994;173:246-252.
36. Report of the consensus development conference on antenatal corticosteroids revisited: Repeat courses; 2000; 2000.
37. Ng P.,Wong G.,Lam C.,Lee C.,Fok T.,Wong M.,Ma K.Effect of multiple courses of antenatal corticosteroids on pituitary-adrenal function in preterm infants.Archives of Disease in the Child, Fetal and Neonatal Edition. 1999;80:F213-F216.
38. Owen D.,Andrews M.,Matthews S.Maternal adversity, glucocorticoids and the programming of neuroendocrine function and behavior.Neuroscience and Biobehavioral Reviews. 2005;29:209-226.
39. Peabody J.Interpreting risks of steroids for preterm infants.Journal of Pediatrics. 2000;137:590-592.
40. Perlman J. M.Neurobehavioral deficits in premature graduates of intensive care-Potential medical and neonatal environmental risk factors.Pediatrics. 2001;108:1339-1348.
41. Piecuch R.,Leonard C.,Cooper B.,Sehring S.Outcome of extremely low birth weight infants (500 to 999 grams) over a 12-year period.Pediatrics. 1997;100:633-639.
42. Purdy I. B.,Smith L. M.,Wiley D.,Howes C.,Gawlinski A.,Robbins W.,Badr L.Cumulative perinatal steroids: Child development of preterm infants.Journal of Pediatric Nursing. 2008;23:210-214.
43. Richardson D.,Corcoran J.,Escobar G.,Lee S.SNAP-II and SNAPPE-II: Simplified newborn illness severity and mortality risk scores.Journal of Pediatrics. 2001;138:92-100.
44. Saigal S.,Pinelli J.,Houtl L.,Kim M.,Boyle M.Psychopathology and social competencies of adolescents who were extremely low birth weight.Pediatrics. 2003;111:969-975.
45. Shoener J.,Baig R.,Page K.Prenatal exposure to dexamethasone alters hippocampal drive on hypothalamic-pituitary-adrenal axis activity in adult male rats.American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 2006;290:R1366-R1373.
46. Slotkin T.,Kreider M.,Tate M.,Seidler F.Critical prenatal and postnatal periods for persistent effects of dexamethasone on serotonergic and dopaminergic systems.Neuropsychopharmacology. 2006;31:904-911.
47. Smolkin T.,Steinberg M.,Sujov P.,Mezer E.,Tamir A.,Makhoul I.Late postnatal systemic steroids predispose to retinopathy of prematurity in very-low-birth-weight infants: A comparative study.Acta Paediatrica. 2008;97:322-326.
48. Sparrow S.,Balla D.,Cicchetti D.Vineland adaptive behavior scales survey form manual. Circle Pines, MN: American Guidance Incorporated; 1984:.
49. Stark A.,Carlo W.,Tyson J.,Papile L.,Wright L.,Shankaran S.Adverse effects of early dexamethasone in extremely-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network.New England Journal of Medicine. 2001;344:95-101.
50. Stoll B. J.,Gordon T.,Korones S. B.Early-onset sepsis in very low birth weight neonates: A report from the National Institute of Child Health and Human Development Neonatal Research Network.Journal of Pediatrics. 1996;129:63-80.
51. Walsh M.,Yao Q.,Horbar J.,Carpenter J.,Lee S.,Ohlsson A.Changes in the use of postnatal steroids for bronchopulmonary dysplasia in 3 large neonatal networks.Pediatrics. 2006;118:1328-1335.
52. Yeh T. F.,Lin Y. J.,Lin H. C.,Huang C. C.,Hsieh W. S.,Lin C. H.,Tsai C. H.Outcomes at school age after postnatal dexamethasone therapy for lung disease of prematurity.New England Journal of Medicine. 2004;350:1304-1313.